These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3926135)
1. Lack of effect of oral magnesium on high blood pressure: a double blind study. Cappuccio FP; Markandu ND; Beynon GW; Shore AC; Sampson B; MacGregor GA Br Med J (Clin Res Ed); 1985 Jul; 291(6490):235-8. PubMed ID: 3926135 [TBL] [Abstract][Full Text] [Related]
2. Does oral calcium supplementation lower high blood pressure? A double blind study. Cappuccio FP; Markandu ND; Singer DR; Smith SJ; Shore AC; MacGregor GA J Hypertens; 1987 Feb; 5(1):67-71. PubMed ID: 3295037 [TBL] [Abstract][Full Text] [Related]
3. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Witteman JC; Grobbee DE; Derkx FH; Bouillon R; de Bruijn AM; Hofman A Am J Clin Nutr; 1994 Jul; 60(1):129-35. PubMed ID: 8017327 [TBL] [Abstract][Full Text] [Related]
4. Moderate potassium supplementation in essential hypertension. MacGregor GA; Smith SJ; Markandu ND; Banks RA; Sagnella GA Lancet; 1982 Sep; 2(8298):567-70. PubMed ID: 6125727 [TBL] [Abstract][Full Text] [Related]
5. [Moderate supplementation of potassium in essential hypertension]. MacGregor GA; Smith SJ; Markandu ND; Banks RA; Sagnella GA Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():93-100. PubMed ID: 6428368 [TBL] [Abstract][Full Text] [Related]
6. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. Dodson PM; Beevers M; Hallworth R; Webberley MJ; Fletcher RF; Taylor KG BMJ; 1989 Jan; 298(6668):227-30. PubMed ID: 2493869 [TBL] [Abstract][Full Text] [Related]
7. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. MacGregor GA; Markandu ND; Singer DR; Cappuccio FP; Shore AC; Sagnella GA Br Med J (Clin Res Ed); 1987 Feb; 294(6571):531-4. PubMed ID: 3103761 [TBL] [Abstract][Full Text] [Related]
8. Nutritional magnesium supplementation does not change blood pressure nor serum or muscle potassium and magnesium in untreated hypertension. A double-blind crossover study. Plum-Wirell M; Stegmayr BG; Wester PO Magnes Res; 1994 Dec; 7(3-4):277-83. PubMed ID: 7786691 [TBL] [Abstract][Full Text] [Related]
9. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. MacGregor GA; Markandu ND; Best FE; Elder DM; Cam JM; Sagnella GA; Squires M Lancet; 1982 Feb; 1(8268):351-5. PubMed ID: 6120346 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure response during long-term treatment with magnesium is dependent on magnesium status. A double-blind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Lind L; Lithell H; Pollare T; Ljunghall S Am J Hypertens; 1991 Aug; 4(8):674-9. PubMed ID: 1930849 [TBL] [Abstract][Full Text] [Related]
11. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Smith SJ; Markandu ND; Sagnella GA; MacGregor GA Br Med J (Clin Res Ed); 1985 Jan; 290(6462):110-3. PubMed ID: 3917702 [TBL] [Abstract][Full Text] [Related]
12. Does increasing potassium intake lower blood pressure in essential hypertension? MacGregor GA; Smith SJ; Markandu ND; Sagnella GA J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S244-9. PubMed ID: 6204149 [TBL] [Abstract][Full Text] [Related]
13. Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet. Nowson CA; Morgan TO Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):299-302. PubMed ID: 2663263 [TBL] [Abstract][Full Text] [Related]
14. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Zemel PC; Zemel MB; Urberg M; Douglas FL; Geiser R; Sowers JR Am J Clin Nutr; 1990 Apr; 51(4):665-9. PubMed ID: 2181860 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of potassium and magnesium in essential hypertension: a double-blind, placebo controlled, crossover study. Patki PS; Singh J; Gokhale SV; Bulakh PM; Shrotri DS; Patwardhan B BMJ; 1990 Sep; 301(6751):521-3. PubMed ID: 2207419 [TBL] [Abstract][Full Text] [Related]
16. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: a double-blind, cross-over study. Wirell MP; Wester PO; Stegmayr BG J Intern Med; 1994 Aug; 236(2):189-95. PubMed ID: 7913949 [TBL] [Abstract][Full Text] [Related]
17. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group. Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973 [TBL] [Abstract][Full Text] [Related]
18. Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. Erwteman TM; Nagelkerke N; Lubsen J; Koster M; Dunning AJ Br Med J (Clin Res Ed); 1984 Aug; 289(6442):406-9. PubMed ID: 6432119 [TBL] [Abstract][Full Text] [Related]
19. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations. Dols W; Verho M; Rangoonwala B; Jaeger S J Int Med Res; 1985; 13(1):31-9. PubMed ID: 3884409 [TBL] [Abstract][Full Text] [Related]
20. Anti-hypertensive treatment with magnesium-aspartate-dichloride and its influence on peripheral serotonin metabolism in man: a subacute study. Sebeková K; Revúsová V; Polakovicová D; Drahosová J; Zverková D; Dzúrik R Cor Vasa; 1992; 34(5-6):390-401. PubMed ID: 1285056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]